Notice2021-18041
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 23, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 160 (Monday, August 23, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Page 47124]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-18041]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; The Autoantigens and
Neoantigens Function in the Etiology and Pathophysiology of T1D.
Date: October 22, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Diabetes and Digestive and Kidney
Diseases, NIH, 6707 Democracy Boulevard, Room 7007, Bethesda, MD
20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Review Branch, Division of
Extramural Activities, NIDDK, NIH, 6707 Democracy Boulevard, Room
7007, Bethesda, MD 20892, Phone: 301-496-7050, <a href="/cdn-cgi/l/email-protection#c5b1aca4aba985abaca1a1aeebabacadeba2aab3"><span class="__cf_email__" data-cfemail="ee9a878f8082ae80878a8a85c0808786c0898198">[email protected]</span></a>.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Development of
Swallowable Smart Pills/Devices (phased R21/R33).
Date: November 2, 2021.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Diabetes and Digestive and Kidney
Diseases, NIH, 6707 Democracy Boulevard, Room 7007, Bethesda, MD
20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Review Branch, Division of
Extramural Activities, NIDDK, NIH, 6707 Democracy Boulevard, Room
7007, Bethesda, MD 20892, Phone: 301-496-7050, <a href="/cdn-cgi/l/email-protection#dda9b4bcb3b19db3b4b9b9b6f3b3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="b2c6dbd3dcdef2dcdbd6d6d99cdcdbda9cd5ddc4">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18041 Filed 8-20-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 23, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.